Basic synovial biology and immunopathology in psoriatic arthritis

Journal of Rheumatology

Volumn 36, Issue SUPPL. 83, 2009, Pages 14-16

  Robinson, Helena ^a   Kelly, Stephen ^a   Pitzalis, Costantino ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Bone Morphogenetic Pathways; Bone Remodeling; Dickkopf 1; Osteoprotegerin; Psoriatic Arthritis; Rank Ligand

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 6; CELL ADHESION MOLECULE; CYTOKINE; DICKKOPF 1 PROTEIN; HLA ANTIGEN; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 6; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOGENIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; DKK1 PROTEIN, HUMAN; OSTEOPROTEGERIN; SIGNAL PEPTIDE; TNFSF11 PROTEIN, HUMAN;

ALGORITHM; ANKYLOSIS; B LYMPHOCYTE; BONE EROSION; BONE MINERALIZATION; BONE REMODELING; CONFERENCE PAPER; HUMAN; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; INFLAMMATORY INFILTRATE; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; PERIOSTITIS; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PSORIATIC ARTHRITIS; SIGNAL TRANSDUCTION; SYNOVIUM; T LYMPHOCYTE; ULTRASOUND; VASCULARIZATION; ARTICLE; IMMUNOLOGY; NEOVASCULARIZATION (PATHOLOGY); PATHOPHYSIOLOGY; PHYSIOLOGY;

ARTHRITIS, PSORIATIC; BONE REMODELING; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; OSTEOPROTEGERIN; RANK LIGAND; SYNOVIAL MEMBRANE;

EID: 70349917873     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.090212     Document Type: Conference Paper

References (26)

1. Kane D, Stafford L, Bresnihan B, Fitzgerald O. A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. Rheumatology 2003;42:1460-1468 (Pubitemid 37508919)
2. McHugh NJ, Balachrishnan C, Jones SM. Progression of peripheral joint disease in psoriatic arthritis: a 5-yr prospective study. Rheumatology 2003;42:778-783 (Pubitemid 37220911)
3. Mease PJ, Gladman DD, Keystone EC. Alefacept in combination with methotrexate for the treatment of psoriatic arthritis: results of a randomized, double-blind, placebo controlled study. Arthritis Rheum 2006;54:163-245
4. Utset TO, Auger JA, Peace D, et al. Modified anti CD3 therapy in psoriatic arthritis: a phase I/II clinical trial. J Rheumatol 2002;29:1907-1913 (Pubitemid 34988699)
5. Costello PJ, Winchester RJ, Curran SA, et al. Psoriatic arthritis joint fluids are characterized by CD8 and CD4 T cell clonal expansions appear antigen driven. J Immunol 2001;166:2878-2886
6. Laloux L, Voisin MC, Allain J, et al. Immunohistological study of entheses in spondyloarthropathies: comparison in rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 2001;60:316-321 (Pubitemid 32242741)
7. Zenz R, Eferl R, Kenner L, et al. Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature 2005;437:369-375 (Pubitemid 41613493)
8. Fearon U, Griosios K, Fraser A, et al. Angiopoietins, growth factors, and vascular morphology in early arthritis. J Rheumatol 2003;30:260-268 (Pubitemid 36152587)
9. Espinoza LR, Vasey FB, Espinoza CG, Bocanegra TS, Germain BF. Vascular changes in psoriatic synovium. A light and electron microscopic study. Arthritis Rheum 1982;25:677-684
10. Canete JD, Rodriguez JR, Salvador G, Gomez Centeno A, Munoz Gomez J, Sanmarti R. Diagnostic usefulness of synovial vascular morphology in chronic arthritis. A systematic survey of 100 cases. Semin Arthritis Rheum 2003;32:378-387
11. van Kuijk AW, Reinders Blankert P, Smeets TJ, Dijkmans BA, Tak PP. Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment. Ann Rheum Dis 2006;65:1551-1557
12. Pitzalis C, Cauli A, Pipitone N, et al. Cutaneous lymphocyte antigen positive T lymphocytes preferentially migrate to the skin but not to the joint in psoriatic arthritis. Arthritis Rheum 1996;39:137-145 (Pubitemid 26036388)
13. Fraser AD, van Kuijk AW, Westhovens R, et al. A randomised, double-blind, placebo controlled, multicentre trial of combination therapy with methotrexate plus ciclosporin in patients with active psoriatic arthritis. Ann Rheum Dis 2005;64:859-864 (Pubitemid 40733909)
14. Nakae S, Nambu A, Sudo K, Iwakura Y. Suppression of immune induction of collagen induced arthritis in IL-17 deficient mice. J Immunol 2003;171:6173-6177 (Pubitemid 37467240)
15. Chabaud M, Durand JM, Buchs N, et al. Human interleukin 17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum 1999;42:963-970 (Pubitemid 29215007)
16. Lee E, Trepicchio WL, Oestreicher JL, et al. Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J Exp Med 2004;199:125-130 (Pubitemid 38076484)
17. Kong YY, Yoshida H, Sarosi I, et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis. Nature 1999;397:315-323 (Pubitemid 29061638)
18. Redlich K, Hayer S, Ricci R, et al. Osteoclasts are essential for TNF-alpha-mediated joint destruction. J Clin Invest 2002;110:1419-1427 (Pubitemid 35396913)
19. Ritchlin CT, Haas-Smith SA, Li P, Hicks DG, Schwarz EM. Mechanisms of TNF alpha and RANKL mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J ClinInvest 2003;111:821-831 (Pubitemid 37074957)
20. Danning CL, Illei GG, Hitchon C, Greer MR, Boumpas DT, McInnes IB. Macrophage derived cytokine and nuclear factor kappa B p65 expression in synovial membrane and skin of patients with psoriatic arthritis. Arthritis Rheum 2000;43:1244-1256 (Pubitemid 30416309)
21. Kavanaugh A, Antoni CE, Gladman D, et al. The Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT): results of radiographic analyses after 1 year. Ann Rheum Dis 2006;65:1038-1043 (Pubitemid 44133266)
22. Diarra D, Stolina M, Polzer K, et al. Dickkopf 1 is a master regulator of joint remodeling. Nat Med 2007;13:156-163 (Pubitemid 46245765)
23. Luyten FP, Lories RJ, Verschueren P, de Vlam K, Westhovens R. Contemporary concepts of inflammation, damage and repair in rheumatic diseases. Best Pract Res Clin Rheumatol 2006;20:829-848 (Pubitemid 44356463)
24. Lories RJ, Derese I, Luyten FP.Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis. J Clin Invest 2005;115:1571-1579 (Pubitemid 40814665)
25. Kelly S, Taylor P, Pitzalis C. Ultrasound imaging in spondyloarthropathies: from imaging to diagnostic intervention. Curr Opin Rheumatol 2008;20:408-415
26. Scire CA, Epis O, Codullo V, et al. Immunohistological assessment of the synovial tissue in small joints in rheumatoid arthritis: validation of a minimally invasive ultrasound guided synovial biopsy procedure. Arthritis Res Ther 2007;9:R101. (Pubitemid 350162911)